HMGB1 and non-small cell lung carcinoma: Niki et al. [162] found that the number of PMPs in NSCLC correlated with the levels of high-mobility group box-1 (HMGB1) and plasminogen activator inhibitor-1 (PAI-1), and that the combined increase in all three parameters was associated with the prognosis of NSCLC.